4.6 Article

COVID-19: An Update about the Discovery Clinical Trial

Journal

PHARMACEUTICALS
Volume 13, Issue 5, Pages -

Publisher

MDPI
DOI: 10.3390/ph13050098

Keywords

chloroquine; COVID-19; hydroxychloroquine; lopinavir; ritonavir; plasma; remdesivir; SARS-CoV-2

Ask authors/readers for more resources

Finding efficacious and safe treatments for COVID-19 emerges as a crucial need in order to control the spread of the pandemic. Whereas plasma therapy attracts much interest, the European project Discovery focuses on the potentialities of small molecules like remdesivir, the combination of lopinavir/ritonavir, hydroxychloroquine, and chloroquine. Results recently published on the clinical evaluation of those drugs are compiled in this brief report, although complete data are still impatiently awaited.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available